Search
for
Sort by
Research 151–180 of 396
- NON-PSORALEN TREATMENT OF VITILIGO. PART II. LESS COMMONLY USED AND EXPERIMENTAL THERAPIES
- Systemic causes of hair loss
- The quality of European dermatological guidelines: critical appraisal of the quality of EDF guidelines using the AGREE II instrument
- Primary Cicatricial Alopecias
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- Demodex Folliculitis of the Scalp: Clinicopathological Study of an Uncommon Entity
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Contact dermatitis to phenol‐formaldehyde resin in two plywood factory workers
- IMMUNOPATHOLOGY OF THE HUMAN HAIR FOLLICLE
- Cutaneous Blood Flow.
- Cicatricial (scarring) alopecia
- Hair loss
- Experiences From a Combined Dermatology and Rheumatology Clinic
- Immunomodulators in the treatment of cutaneous lymphoma
- Dermal mucin in alopecia areata – tell tale sign or incidental finding?
- The Polish version of Skindex-29: psychometric properties of an instrument to measure quality of life in dermatology
- Focal and Generalized Alopecia
- Diseases of Periocular Hair
- Biology of the skin and dermatological disease
- Increasing Access to Specialized Dermatology Care: A Retrospective Study Investigating Clinical Operation and Impact of a University-Affiliated Free Clinic
- Adverse cutaneous effects of psychotropic medications
- Female-patterned alopecia in teenage brothers with unusual histologic features
- Combination of tacalcitol ointment and photodynamic therapy for the treatment of follicular mucinosis of the scalp
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Cutaneous Markers of Disorders Affecting Adult Horses
- Integrated single-cell chromatin and transcriptomic analyses of peripheral immune cells in patients with alopecia areata
- Body Dysmorphic Disorder, Psychiatric Symptoms, and Quality of Life in Female Dermatological Patients
- Dermoscopy: distinguishing malignant tumors from benign
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Urticaria, Drug Hypersensitivity Rashes, Nodules and Tumors, and Atrophic Diseases